# Lydus Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lydus-medical

- Industry: Medical Devices & Equipment
- Headquarters: Ra'anana, Israel
- Website: www.lydus-medical.com
- Total disclosed funding: $2.7M
- Latest round: Seed (May 24, 2021)
- Investors on record: 4

## About

Lydus Medical is a specialized medical device company focused on advanced microvascular anastomosis solutions, offering innovative products that enhance surgical outcomes in complex microsurgery.Founded in 2017 and headquartered in Ra'anana, Israel, Lydus Medical develops solutions for microvascular anastomosis. The company's flagship product is the Vesseal™ automated microvascular suturing device. In May 2021, Lydus Medical raised USD 2.7 mn in Seed funding to support its growth and product development initiatives. The current CEO is Jessica Weiss, who leads the company as it navigates the evolving landscape of surgical technologies.Lydus Medical specializes in microvascular anastomosis solutions, primarily through its flagship product, the Vesseal™ automated microvascular suturing device. This device facilitates standardized omni-vessel anastomoses for vessels from 0.5 to 4 mm in diameter, addressing challenges in cardiovascular, transplant, and reconstructive microsurgery. The Vesseal™ device aims to streamline surgical procedures, significantly reducing ischemic time and operation duration. Target end users include hospitals, surgical centers, and microsurgeons in reconstructive surgery, organ transplantation, and peripheral bypass, with markets in North America, Europe, and select regions of Asia.Lydus Medical’s revenue generation model is based on direct sales of its Vesseal™ device to healthcare institutions, including hospitals and surgical centers specializing in microsurgery. The sales structure involves direct-to-consumer transactions where medical facilities procure the device and associated supplies via negotiated agreements. The pricing reflects the advanced technology and specialized application of the product, ensuring competitiveness within the surgical device market. Revenue is expected from initial device sales and ongoing supplies necessary for operation, facilitating repeat business from clients.In May 2021, Lydus Medical raised USD 2.7 mn in Seed funding, which will be utilized to accelerate FDA clearance and scale its product development. The company plans to design and launch new products, expanding its offerings in the microvascular surgery space. Additionally, Lydus Medical aims to penetrate new markets, focusing on regions in North America and Europe by 2023, enhancing its global presence and service delivery.

## Funding rounds

- Seed, May 24, 2021, $2.7M — GlenRock Israel, Sanara Ventures, Technion - Israel Institute of Technology, Mor Research Applications Ltd.

## Investors

- GlenRock Israel (https://capitalatlas.ai/funds/glenrock-israel) — Seed
- Sanara Ventures (https://capitalatlas.ai/funds/sanara-ventures) — Seed
- Technion - Israel Institute of Technology — Seed
- Mor Research Applications Ltd. — Seed